Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Express Scripts, FTC
Cigna's Express Scripts sues FTC over 'defamatory' PBM report
Cigna's Express Scripts, one of the country's largest pharmacy benefit managers, today sued the Federal Trade Commission and its chair, Lina Khan, over what the company asserts was a report filled with false and misleading claims about how pharmacy benefit management firms operate.
FTC sues drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission on Friday sued three large U.S. health companies that negotiate insulin prices, arguing the drug middlemen boost their profits while "artificially" inflating costs for patients.
Cigna’s PBM Express Scripts sues the FTC, seeking retraction of drug-cost report
Cigna Group’s pharmacy benefit manager Express Scripts on Tuesday sued the U.S. Federal Trade Commission, alleging that the agency’s July report on the PBM industry was biased and defamatory and asking the court to order the FTC to withdraw the report.
Express Scripts Sues FTC Over PBM Report
Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry.
Express Scripts sues FTC over report scrutinizing PBM practices
As the FTC has increasingly prodded PBMs over their role in high drug costs, Express Scripts is fighting back by launching a lawsuit against the agency.
FTC sues three largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged anticompetitive practices that boosted profits while
Express Scripts sues FTC over 'flawed and biased' PBM report
Express Scripts parent company Cigna alleges the Federal Trade Commission ignored more than 3 million pages of documents the pharmacy provided to investigators.
Express Scripts files suit against FTC, demands retraction of report on PBM industry
Express Scripts has filed suit against the Federal Trade Commission, demanding that the agency retract a damning report on the pharmacy benefit management industry. | Express Scripts has filed suit against the Federal Trade Commission,
PBM strikes back at FTC over drug pricing report
The complaint, filed by Express Scripts owner Cigna against the FTC and Commissioner Lina Khan, is seeking the retraction of the report, which the company claims is "unfair, biased, erroneous, and defamatory" against the PBM industry and is "seventy-four pages of unsupported innuendo."
Express Scripts sues FTC and demands drug pricing report retraction
The US-based pharmacy benefit manager (PBM) claims that the FTC’s July 2024 report is riddled with “false and misleading claims” about the PBM industry.
Cigna's Express Scripts Sues FTC, Demands Withdrawal Of PBM Report; Stock Down
Express Scripts by Evernorth, a unit of Cigna Group (CI), Tuesday said it has filed a lawsuit against the Federal Trade Commission or
health.wusf.usf.edu
2h
FTC sues insulin middlemen, saying they pocket billions while patients face high costs
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
The American Journal of Managed Care
1d
FTC Takes Legal Action Against 3 Largest PBMs Over Insulin Costs
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
Fierce Healthcare
1d
FTC formally sues PBMs over insulin prices and warns manufacturers
Express Scripts files suit against
FTC
, demands retraction of report on
PBM
industry These PBMs value high rebates from ...
1d
High Insulin Prices Spur a Federal Lawsuit Against Three Pharmacy Benefit Managers
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback